Partner Headlines - ICPT

  1. Keep an Eye on These 7 Stocks for February 16, 2016

    Benzinga
  2. Benzinga's Weekend M&A Chatter

    Benzinga
  3. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD
  4. Intercept Pharmaceuticals Soars 30%; Reuters Reported Company ...

    Benzinga
  5. Benzinga's Top Upgrades

    Benzinga
  6. BioMarin, Intercept hit by FDA

    IBD
  7. BioMarin, Intercept Pharma Drugs Face FDA Delays

    IBD
  8. INTERCEPT PHARMA

    IBD
  9. Intercept Pharma Higher On Takeover Rumor

    Benzinga
  10. Intercept Presents New Data Analyses on Non-Invasive Liver Testing ...

    Benzinga
  11. Intercept Presents New Primary Biliary Cholangitis Data at AASLD ...

    Benzinga
  12. Benzinga's M&A Chatter for Tuesday November 10, 2015

    Benzinga
  13. Intercept Pharmaceuticals

    IBD
  14. Intercept Pharmaceuticals Rebounds After Phase 2 Trial Of OCA ...

    Benzinga
  15. Intercept Pharma NASH Drug Disappoints In Japan

    IBD
  16. Mid-Morning Market Update: Markets Open Higher; Hershey Earnings ...

    Benzinga
  17. Morning Market Losers

    Benzinga
  18. Mid-Morning Market Update: Markets Open Lower; Carlyle Group ...

    Benzinga
  19. Morning Market Gainers

    Benzinga
  20. FDA Grants Priority Review for Intercept's Obeticholic Acid for ...

    Benzinga
  21. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga
  22. Sportsman's Warehouse, Bob Evans, Peabody Energy Lead Tuesday's ...

    Benzinga
  23. Benzinga's Top Initiations

    Benzinga
  24. Barclays Initiates Intercept Pharmaceuticals With Overweight

    Benzinga
  25. Intercept Pharmaceuticals Inc (ICPT) Moves Forward With OCA REGENERATE ...

    GuruFocus
  26. Intercept has a design for test

    IBD
  27. Intercept's NASH Trial Design Irks Investors

    IBD
  28. Will The Bulls In Options Continue To Be Disappointed This Week?

    Benzinga
  29. Analysts are Positive on Intercept Pharmaceuticals Inc Following ...

    GuruFocus
  30. Earnings Scheduled For March 2, 2015

    Benzinga
  31. Making Money With Charles Payne: 02/06/15

    FoxBusiness
  32. Wedbush Highlights 2015 Catalysts for Emerging BioPharmaceuticals ...

    GuruFocus
  33. Cowen And Company Analyst Explains Why Intercept Pharmaceuticals ...

    Benzinga
  34. Cowen Analyst Likes Intercept Pharmaceuticals, ACADIA Pharmaceuticals ...

    Benzinga
  35. Mid-Afternoon Market Update: Crude Oil Jumps 7.5%; Visa Shares ...

    Benzinga
  36. Intercept Pharmaceuticals Soars 20%, Possible Short Squeeze

    Benzinga
  37. Mid-Day Market Update: Amazon Jumps On Upbeat Earnings; Hawaiian ...

    Benzinga
  38. Intercept Pharmaceuticals (ICPT) Obeticholic Acid Momentum, Gigamon ...

    GuruFocus
  39. Benzinga's Volume Movers

    Benzinga
  40. Mid-Morning Market Update: Markets Drop; Mastercard Profit Tops ...

    Benzinga
  41. Morning Market Gainers

    Benzinga
  42. Friday Morning Movers: Amazon Pops, Deckers Outdoor Plummets ...

    Benzinga
  43. Stock Futures Sharpen Losses; Amazon, Visa, MasterCard Climb

    IBD
  44. Benzinga's Top #PreMarket Gainers

    Benzinga
  45. INTERCEPT PHARMACEUTICALS

    IBD
  46. Deutsche Bank: No Big Move In FY15 For Intercept Pharmaceuticals

    Benzinga
  47. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  48. Gilead Acquires Drug Program For Fatty Liver Disease

    IBD
  49. IPO Stock Watch: FibroGen Up With Liver-Disease Field

    IBD
  50. Making Money With Charles Payne: 12/22/14

    FoxBusiness
  51. Intercept Announces Publication Of Meta-Analysis From The Global ...

    Benzinga
  52. Here Are The Top 25 Analysts On Wall Street

    Benzinga
  53. Stock Movers: Why Medicals Issues Are Dipping Today

    IBD
  54. Mid-Afternoon Market Update: Lions Gate Surges On Earnings Beat; ...

    Benzinga
  55. Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, ...

    Benzinga
  56. Morning Market Losers

    Benzinga
  57. Benzinga's Top #PreMarket Losers

    Benzinga
  58. Meet The 5 Companies Loving Obamacare

    Benzinga
  59. Morning Market Losers

    Benzinga
  60. Benzinga's Top #PreMarket Losers

    Benzinga
  61. Benzinga's Top Initiations

    Benzinga
  62. Cowen Initiates Intercept At Outperform

    Benzinga
  63. Four biotech takeover targets?

    IBD
  64. 4 Biotechs That Might Be Bought Soon

    IBD
  65. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  66. Morning Market Losers

    Benzinga
  67. Benzinga's Top #PreMarket Losers

    Benzinga
  68. CNBC's Stock Pops & Drops From August 12

    Benzinga
  69. Markets Marginally Lower In Quiet Trading Session

    Benzinga
  70. U.S. Job Openings Climb; Leerink Swann Bullish On Intercept Pharmaceuticals

    Benzinga
  71. U.S. Stocks Fall; Dealertrack Shares Surge On Upbeat Results

    Benzinga
  72. Markets Mostly Flat; Flowers Foods Profit Misses Estimates

    Benzinga
  73. Stocks Stake Out Thin Gains; Intercept, Insys, Autohome Gain

    IBD
  74. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD
  75. Benzinga's Volume Movers

    Benzinga
  76. Morning Market Movers

    Benzinga
  77. Conatus Shares Move Higher On Industry Data

    Benzinga
  78. Stock Futures Hem And Haw; Intercept Pharmaceuticals Soars

    IBD
  79. Benzinga's Top #PreMarket Gainers

    Benzinga
  80. Intercept Pharma Soars On Positive Liver Drug Data

    IBD
  81. INTERCEPT PHARMACEUTICALS

    IBD
  82. Intercept Pharmaceutical's Shares Soar On Earnings

    Benzinga
  83. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus
  84. Intercept Pharmaceutical Shares Up Amid Deutsche Bank Initiation

    Benzinga
  85. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  86. Benzinga's Top Initiations

    Benzinga
  87. Analysts Comment On Intercept Amid Share Decline Following FLINT ...

    Benzinga
  88. Top Healthcare Movers For June 9, 2014

    Benzinga
  89. Market Wrap For April 14: Markets Surge on Positive Retail Data, ...

    Benzinga
  90. Weekly CFO Sells Highlight: Intercept Pharmaceuticals Inc., ...

    GuruFocus
  91. Intercept Issues Preclinical Data Showing OCA's Potential Role ...

    Benzinga
  92. US Stock Futures Nudge Higher Ahead Of Jobs Data

    Benzinga
  93. Market Wrap For March 17: Investors Focused On Economic Data ...

    Benzinga
  94. Intercept Pharmaceuticals Announces Q4 Earnings

    Benzinga
  95. Stocks Near Session Highs; Kandi Up 26% On Q4 Results

    IBD
  96. Top Trending Tickers On StockTwits For March 17

    Benzinga
  97. Benzinga's Top #PreMarket Losers

    Benzinga
  98. Morning Gainers for Friday, March 14, 2014

    Benzinga
  99. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  100. Shares of Intercept Pharma Rise as BofA Sees US, EU Regulators ...

    Benzinga
Trading Center